Amryt Pharma gets EU approval for Mycapssa drug
Irish pharmaceutical company Amryt said today that the European Commission had approved its Mycapssa drug in the European Union for the maintenance treatment of acromegaly in patients who have responded to and tolerated treatment with octreotide or lanreotide.
Business
• 05 Dec 22
